Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

Market Cap	4.29B -1.9%
Revenue (ttm)	2.20B -13.1%
Net Income	319.41M +34.4%
EPS	0.46 +38.1%
Shares Out	692.00M
PE Ratio	13.51
Forward PE	n/a
Dividend	0.30 (4.84%)
Ex-Dividend Date	Jun 15, 2026

Volume	13,716,093
Open	6.07
Previous Close	6.05
Day's Range	6.05 - 6.21
52-Week Range	5.60 - 8.68
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 1, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 3,415
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600351

Financial Performance

In 2025, SHA:600351's revenue was 2.24 billion, a decrease of -16.60% compared to the previous year's 2.69 billion. Earnings were 320.01 million, an increase of 31.86%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error